Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-02

Clinical Trial Update: CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a text messaging intervention to improve adherence to PrEP among high-risk men who have sex with men; completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: Patient Adherence, HIV Seronegativity | Phase 4 | Status: COMPLETED | Results posted: 2020-06-02